The Bioplatforms Australia investment cuts across the platforms of Genomics, Proteomics, Metabolomics and Bioinformatics. Coordination of each aspects of these investments is managed through
- Genomics Australia – high throughput gene sequencing, transcript analysis, epigenetics and bioinformatics
- Proteomics Australia – protein separation, mass spectrometry, monoclonal antibody development and protein chemistry
- Metabolomics Australia – sample preparation, metabolite profiling, mass spectrometry
- Australian Bioinformatics Facility – experimental planning, data acquisition, data interrogation and data reporting
Integration of the platform technologies and services on offer through the Bioplatforms Australia investment is a key outcome of the investment. Researchers can access all aspects of the investment to maximize their research quality and output.
Bioplatforms Australia was established to manage an Australian Commonwealth Government investment through the National Collaborative Research Infrastructure Strategy (NCRIS) with support from State Governments, Academic and Research Institutes and commercial entities.